290 related articles for article (PubMed ID: 28964592)
21. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
22. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
23. Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.
Song B; Wang L; Zhang Y; Li N; Dai H; Xu H; Cai H; Yan J
Cancer Biother Radiopharm; 2019 Mar; 34(2):85-90. PubMed ID: 30585764
[TBL] [Abstract][Full Text] [Related]
24. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
25. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study.
Hsiao WC; Young KC; Lin SL; Lin PW
Breast Cancer Res; 2004; 6(3):R180-6. PubMed ID: 15084241
[TBL] [Abstract][Full Text] [Related]
27. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
28. Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population.
Bayram S; Sümbül AT; Batmacı CY; Genç A
Tumour Biol; 2015 May; 36(5):3863-70. PubMed ID: 25586347
[TBL] [Abstract][Full Text] [Related]
29. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population.
Hashemi M; Sanaei S; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):69-73. PubMed ID: 26718432
[TBL] [Abstract][Full Text] [Related]
30. Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population.
Patricia Gallegos-Arreola M; Zúñiga González GM; Figuera LE; Puebla Pérez AM; Delgado Saucedo JI
J BUON; 2019; 24(6):2369-2376. PubMed ID: 31983108
[TBL] [Abstract][Full Text] [Related]
31. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
32. The rs2234694 and 50 bp Insertion/Deletion polymorphisms of the SOD1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Ramírez-Hernández MA; Figuera LE; Zúñiga-González GM; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8017-8027. PubMed ID: 32767328
[TBL] [Abstract][Full Text] [Related]
33. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
[TBL] [Abstract][Full Text] [Related]
34. STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.
Zhao H; Wang Z; Wu H; Xiao Q; Yao W; Wang E; Liu Y; Wei M
Med Oncol; 2015 Jan; 32(1):375. PubMed ID: 25487443
[TBL] [Abstract][Full Text] [Related]
35. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
36. [Survival of patients with metastatic breast cancer according to pathological types of tumors].
Sánchez R C; Acevedo C F; Petric G M; Galindo A H; Domínguez C F; León R A; Razmilic V D; Ceballos C; Espinoza F; Navarro O ME; Oddó B D; Camus A M
Rev Med Chil; 2014 Apr; 142(4):428-35. PubMed ID: 25117032
[TBL] [Abstract][Full Text] [Related]
37. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
39. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
[TBL] [Abstract][Full Text] [Related]
40. CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.
Banin-Hirata BK; Losi-Guembarovski R; Oda JM; de Oliveira CE; Campos CZ; Mazzuco TL; Borelli SD; Ceribelli JR; Watanabe MA
Clin Exp Med; 2016 May; 16(2):139-45. PubMed ID: 25716470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]